Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ESPR > SEC Filings for ESPR > Form 8-K on 13-Jan-2014All Recent SEC Filings

Show all filings for ESPERION THERAPEUTICS, INC.



Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 7, 2014, Esperion Therapeutics, Inc. (the "Company") elected Antonio M. Gotto, Jr., M.D., D. Phil, to the Board of Directors of the Company, effective as of January 13, 2014. Dr. Gotto was elected as a Class II director and will serve until the Company's annual meeting of stockholders in 2015 or until his successor is duly elected and qualified.

Dr. Gotto currently serves as Co-Chairman of the Board of Overseers of the Joan and Sanford I. Weill Medical College of Cornell University and Vice President of Cornell University. From January 1997 to December 2011, Dr. Gotto served as the Stephen and Suzanne Weiss Dean of the Joan and Sanford I. Weill Medical College of Cornell University and Provost for Medical Affairs of Cornell University. Previously, Dr. Gotto served as J.S. Abercrombie Chair of Atherosclerosis and Lipoprotein Research and Chairman and Professor of the Department of Medicine at Baylor College of Medicine and Methodist Hospital. Dr. Gotto currently serves as a member of the Institute of Medicine of the National Academy of Sciences and a Fellow of the American Academy of Arts and Sciences. Dr. Gotto is also a past president of the International Atherosclerosis Society and a past president of the American Heart Association. Dr. Gotto holds a B.A. degree from Vanderbilt University, a D.Phil. degree in Biochemistry from Oxford University in England, where he was a Rhodes Scholar, and an M.D. degree from Vanderbilt University School of Medicine. Dr. Gotto completed his residency training at Massachusetts General Hospital in Boston, Massachusetts. Dr. Gotto is also a member of the Board of Directors of Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR). The Company believes that Dr. Gotto is qualified to serve as a director based on his broad experience in the industry in which it operates.

As a non-employee director, Dr. Gotto will receive cash and equity compensation paid by the Company pursuant to its non-employee director compensation program. There are no arrangements or understandings between Dr. Gotto and any other person pursuant to which Dr. Gotto was selected as a director, and there are no transactions between Dr. Gotto and the Company that would require disclosure under Item 404(a) of Regulation S-K.

* * *

  Add ESPR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ESPR - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.